Catalyst Wire Dossier Catalyst Wire Dossier

Belimumab

belimumab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

62 regulatory and trial events tracked for Belimumab, covering 2012-02-10 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Belimumab in Autoimmune Hepatitis [Phase 2]

See pricing